BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, May 12, 2026
Home » Blogs » BioWorld Perspectives » Welcome to BioWorld.com 14.0

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld

Welcome to BioWorld.com 14.0

Nov. 2, 2011
By Lynn Yoffee

Raise your hand if you remember receiving BioWorld Today via that curly fax paper. Seems like ages ago, right? We used a “fax blaster” in those early days – more than 20 years ago – to deliver your daily dose of biotech news. Technology advanced and 14 years ago BioWorld.com was launched. It was a pretty simple site at the start. Since then we’ve made incremental improvements and additions. Today, however, I’m thrilled to tell you that a spanking new BioWorld.com debuts.

BioWorld’s indispensable, award-winning coverage of the biopharmaceutical industry continues, but now it’s bigger, better and has more. Take our brand new turbo-charged search engine for a test drive. It allows for super precise searching of more than two decades of data on drugs in development. Many more goodies at the new site include quick access to our blog (join the discussion!), an instant poll, video, article bookmarking and much more.

I could go on . . . but you’ve probably guessed that I’m like a new parent showing off photos and kvelling ad nauseam. I’ll stop (for now), but please check it out and let me know what you think.

You have a reason to make BioWorld.com your home page. Visit in the morning to get your daily biopharmaceutical news fix. Then stay for breaking news as it happens, plus analysis, opinion, and so much more.

P.S. Psssssst . . . Though everyone can poke around the site now, non-subscribers have limited access. But we’re planning some free, open-access time in the very near future. Stay tuned for a dates. (Don’t tell our marketing folks; I wasn’t supposed to leak that info just yet.)

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 11, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Neurology illustration

    Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst

    BioWorld
    Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing